Interpretation of metabolic dysfunction and alcohol-related liver disease： Position statement by an expert panel on alcohol-related liver disease （2024 edition）
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 3
Abstract
In November 2024， the Expert Group on Alcohol-related Liver Disease released a position statement on metabolic dysfunction and alcohol-related liver disease （MetALD）. MetALD is a new subtype of steatotic liver disease and refers to MASLD patients with a relatively large amount of alcohol consumption. The position statement points out the importance of accurate evaluation of alcohol consumption and recommends to quantify alcohol consumption using standard methods and alcohol biomarkers， and a comprehensive diagnosis should be made based on metabolic risk factors. In addition， the position statement analyzes the influence of drinking pattern on the diagnosis of MetALD and recommends to consider long-term drinking history during typing. The position statement also discusses the complex association between drinking and the diseases including metabolic syndrome， hepatic steatosis， fibrosis， and type 2 diabetes mellitus， and it is pointed out that the hierarchical management of patients should be optimized based on liver histological models and noninvasive models. The position statement elaborates on the definition of MetALD， drinking assessment， the interaction between alcohol use and metabolic dysfunction， and the methods for comprehensive management of MetALD， in order to facilitate learning and provide guidance for clinicians and researchers in clinical practice.
Authors and Affiliations
Zhenyao JIANG, Binbin ZHANG, Jie LI, Junping SHI
Keywords
Related Articles
- EP ID EP768479
- DOI 10.12449/JCH250308
- Views 9
- Downloads 0
Study on the protective efect and mechanism of paeoniflorin on palmitic acid-induced HepG2 cells
[Objective] To investigate the role and mechanism of action of paeoniflorin （PF） in protecting HepG2 cells induced by palmitic acid （PA）. [Methods] HepG2 cells were stimulated with PA at a concentration of 250 μmol/L...
Interpretation of critical update： AASLD practice guidance on prevention， diagnosis， and treatment of hepatocellular carcinoma
In February 2025， the American Association for the Study of Liver Diseases （AASLD） published online “Critical Update： AASLD Practice Guidance on Prevention， Diagnosis， and Treatment of Hepatocellular Carcinoma”. Th...
Guideline for diagnosis and treatment of liver failure （2024 version）
Liver failure is a severe clinical syndrome of liver disease with an extremely high mortality rate. Over the years， scholars worldwide have continuously investigated various aspects of liver failure， including its defi...
Challenges and strategies for clinical treatment of low-level viremia in chronic hepatitis B patients
Hepatitis B virus （HBV） infection is a global public health issue， affecting the health of 250 million people worldwide. Despite the significant progress in antiviral therapy for HBV， some patients still experience l...
Evaluation and management of nutritional consequences in patients with alcoholic cirrhosis
Patients with alcoholic cirrhosis often experience varying degrees of malnutrition， and the patients with malnutrition are more susceptible to complications such as infections and ascites， which may lead to a poor prog...